AbbVie is reviewing interim results from dermal filler trials, with no specific update date yet. $2 million payment received recently, with no estimated milestone payments for 2025.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
AbbVie is reviewing interim results from dermal filler trials, with no specific update date yet. $2 million payment received recently, with no estimated milestone payments for 2025.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing